(Q30502341)

English

MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents

scientific article published on May 9, 2011

In more languages
default for all languages
No label defined

No description defined

Statements

MET-independent lung cancer cells evading EGFR kinase inhibitors are therapeutically susceptible to BH3 mimetic agents (English)
MET-Independent Lung Cancer Cells Evading EGFR Kinase Inhibitors Are Therapeutically Susceptible to BH3 Mimetic Agents (English)
Said Hafez-Khayyata
Honglian Huang
Balazs Halmos

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit